The scope of the research relates to neurodegenerative disease progression, primarily Alzheimer’s disease and Multiple Sclerosis. The aim is to develop new methods using deep learning and AI for segmenting the brain while combining the already known biomarkers and methodology. The research will focus on developing a better understanding of disease progression and the development of robust and faster AI tools to help diagnose neurodegenerative diseases in the future.
For more information: Brainreader enters into a 3-year-R&D-partnership with Aalborg University